GleamWall
中文EN

ADPT Adaptive Biotechnologies Corp

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1478320 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY17.9%
TTM net income YoY11.4%
TTM EPS YoY13.5%
Revenue 3-yr CAGR18.4%
Net income 3-yr CAGR—

Margins

Gross margin74.2%
Operating margin-16.2%
Net margin-23.7%
FCF margin-3.0%
EBITDA margin-11.6%

Returns

ROE-37.1%
ROA-12.0%
ROIC (approx.)-19.9%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets73.1%
Debt / equity0.00x
Current ratio3.97x
Interest coverage-5.33x

Cash quality & payout

Operating cash flow / net income0.06x
Accruals ratio-11.3%
Payout ratio—
Capex / revenue1.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$83.90M$71.55M$70.87M$71.68M$93.97M$58.88M$52.44M$47.46M
Cost of revenue$19.93M$20.16M$18.71M$18.22M$18.16M$18.00M$16.98M$18.05M
Gross profit$63.97M$51.39M$52.17M$53.46M$75.82M$40.88M$35.46M$29.41M
R&D expense$18.64M$19.15M$23.62M$21.76M$23.67M$24.13M$24.20M$23.19M
SG&A expense$18.46M$21.17M$20.98M$19.56M$17.96M$17.79M$17.40M$18.06M
Operating income-$457,000-$15.77M-$19.21M-$12.77M$10.29M-$25.04M-$29.60M-$33.84M
Interest expense$503,000$2.69M$2.89M$2.95M$2.97M$2.95M$2.90M$2.95M
Net income$2.88M-$39.79M-$20.03M-$13.58M$9.55M-$25.61M-$29.85M-$33.69M
EBITDA$2.72M-$12.47M-$15.82M-$9.14M$14.26M-$20.96M-$25.32M-$29.91M
EPS (basic)0.02-0.25-0.13—0.06-0.17-0.20—
EPS (diluted)0.02-0.25-0.13—0.06-0.17-0.20—
Weighted avg. shares (diluted)186.88M159.86M155.52M—163.16M152.08M149.20M—
Balance sheet
Cash & equivalents$75.61M$169.87M$77.58M$70.50M$55.03M$43.16M$50.65M$47.92M
Short-term investments$223.34M$174.38M$140.75M$156.49M$157.74M$154.71M$142.78M$174.37M
Receivables$66.67M$49.51M$48.31M$50.37M$44.82M$44.28M$43.58M$41.73M
Inventory$10.05M$10.50M$11.21M$9.82M$9.93M$8.40M$8.68M$8.44M
Current assets$392.69M$420.56M$291.81M$300.19M$281.44M$261.86M$256.49M$283.75M
PP&E, net$27.97M$29.45M$30.77M$34.11M$37.50M$41.05M$44.43M$48.62M
Goodwill$118.97M$118.97M$118.97M$118.97M$118.97M$118.97M$118.97M$118.97M
Intangibles$456,000$884,000$1.31M$1.73M$2.15M$2.58M$3.01M$3.42M
Total assets$683.12M$640.68M$505.94M$512.74M$490.61M$496.64M$510.85M$539.38M
Current liabilities$98.97M$87.71M$87.01M$89.92M$83.36M$92.14M$87.81M$98.05M
Short-term debt$0$0$5.80M$4.64M$2.43M$3.07M$2.01M$865,000
Long-term debt$0$0$124.75M$126.57M$129.41M$130.50M$131.55M$132.41M
Total debt$0$0$130.55M$131.21M$131.84M$133.56M$133.56M$133.28M
Total liabilities$499.23M$490.02M$281.70M$287.74M$286.36M$317.10M$320.63M$336.89M
Shareholders' equity$176.21M$142.91M$216.34M$218.79M$204.44M$179.72M$190.42M$202.71M
Net debt-$75.61M-$169.87M$52.97M$60.71M$76.80M$90.40M$82.92M$85.36M
Shares outstanding161.57M159.06M159.70M153.78M152.58M152.23M151.92M147.77M
Cash flow statement
Operating cash flow$9.61M-$6.40M-$9.54M$2.06M-$7.13M-$12.43M-$28.48M-$12.49M
Capital expenditure$1.93M$1.18M$796,000$636,000$409,000$655,000$1.26M$80,000
Free cash flow$7.68M-$7.58M-$10.33M$1.42M-$7.54M-$13.09M-$29.74M-$12.57M
Investing cash flow-$125.06M-$43.48M$9.14M-$8.25M$17.28M$3.35M$25.57M$22.12M
Financing cash flow$21.17M$142.19M$7.50M$21.66M$1.68M$1.61M$5.45M$127,000
Depreciation & amortization$3.18M$3.30M$3.39M$3.63M$3.97M$4.07M$4.29M$3.93M
Stock-based compensation$10.39M$11.12M$11.93M$12.72M$13.26M$13.36M$12.15M$12.83M
Share buybacks$0———$0———

Free plan shows the latest 8 periods; Pro shows all 34 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.